Molecular Docking Simulations with ArgusLab.

Molecular docking is the major computational technique employed in the early stages of computer-aided drug discovery. The availability of free software to carry out docking simulations of protein-ligand systems has allowed for an increasing number of studies using this technique. Among the available free docking programs, we discuss the use of ArgusLab ( http://www.arguslab.com/arguslab.com/ArgusLab.html ) for protein-ligand docking simulation. This easy-to-use computational tool makes use of a genetic algorithm as a search algorithm and a fast scoring function that allows users with minimal experience in the simulations of protein-ligand simulations to carry out docking simulations. In this chapter, we present a detailed tutorial to perform docking simulations using ArgusLab.

[1]  Val Oliveira Pintro,et al.  SAnDReS a Computational Tool for Statistical Analysis of Docking Results and Development of Scoring Functions. , 2016, Combinatorial chemistry & high throughput screening.

[2]  R. Prasad,et al.  In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain , 2012, BMC Research Notes.

[3]  K. Muthusamy,et al.  In silico genome analysis and drug efficacy test of influenza A virus (H1N1) 2009 , 2009, Indian Journal of Microbiology.

[4]  W. F. de Azevedo,et al.  Bio-inspired algorithms applied to molecular docking simulations. , 2011, Current medicinal chemistry.

[5]  W. Azevedo,et al.  Targeting imidazoline site on monoamine oxidase B through molecular docking simulations , 2012, Journal of Molecular Modeling.

[6]  Paula Rahal,et al.  Molecular models of NS3 protease variants of the Hepatitis C virus , 2005, BMC Structural Biology.

[7]  S. Kim,et al.  Structural basis for chemical inhibition of CDK2. , 1996, Progress in cell cycle research.

[8]  R. Dash,et al.  Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer , 2015, Bioinformation.

[9]  Ali Jahanban-Esfahlan,et al.  Interaction of glutathione with bovine serum albumin: Spectroscopy and molecular docking. , 2016, Food chemistry.

[10]  Judith Klein-Seetharaman,et al.  Preferential binding of allosteric modulators to active and inactive conformational states of metabotropic glutamate receptors , 2008, BMC Bioinformatics.

[11]  Gumpeny Ramachandra Sridhar,et al.  In Silico Docking of HNF-1a Receptor Ligands , 2012, Adv. Bioinformatics.

[12]  J. H. Pereira,et al.  Molecular models of protein targets from Mycobacterium tuberculosis , 2005, Journal of molecular modeling.

[13]  N. Lamango,et al.  Biochemical and docking analysis of substrate interactions with polyisoprenylated methylated protein methyl esterase. , 2010, Current cancer drug targets.

[14]  P. Mishra,et al.  Metal Complexes of a Novel Schiff Base Based on Penicillin: Characterization, Molecular Modeling, and Antibacterial Activity Study , 2017, Bioinorganic chemistry and applications.

[15]  P. Fischer,et al.  4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects. , 2006, Journal of medicinal chemistry.

[16]  Bianca Villavicencio,et al.  Recent Progress of Molecular Docking Simulations Applied to Development of Drugs , 2012 .

[17]  Computational repositioning of ethno medicine elucidated gB-gH-gL complex as novel anti herpes drug target , 2013, BMC Complementary and Alternative Medicine.

[18]  Charles L. Brooks,et al.  Assessing energy functions for flexible docking , 1998 .

[19]  L. Moreira-Dill,et al.  A lupane-triterpene isolated from Combretum leprosum Mart. fruit extracts that interferes with the intracellular development of Leishmania (L.) amazonensis in vitro , 2015, BMC Complementary and Alternative Medicine.

[20]  S. Naeem,et al.  Computational study on the geometry optimization and excited - state properties of riboflavin by ArgusLab 4.0.1. , 2013, Pakistan journal of pharmaceutical sciences.

[21]  R. Zabihollahi,et al.  Design of Small Molecules with HIV Fusion Inhibitory Property Based on Gp41 Interaction Assay , 2013, Avicenna journal of medical biotechnology.

[22]  M. Krishnamoorthy,et al.  Docking studies for screening anticancer compounds of Azadirachta indica using Saccharomyces cerevisiae as model system , 2014, Journal of natural science, biology, and medicine.

[23]  Walter Filgueira de Azevedo,et al.  Molecular docking algorithms. , 2008, Current drug targets.

[24]  L. A. Basso,et al.  Virtual Screening of Drugs: Score Functions, Docking, and Drug Design , 2008 .

[25]  Carolina Pasa Vianna,et al.  Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations , 2012, Journal of Molecular Modeling.

[26]  G. C,et al.  A Computational Approach to Identify a Potential Alternative Drug With Its Positive Impact Toward PMP22 , 2017, Journal of cellular biochemistry.

[27]  M. Gopalakrishnan,et al.  One pot synthesis, structural and spectral analysis of some symmetrical curcumin analogues catalyzed by calcium oxide under microwave irradiation. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[28]  R. Pawar,et al.  Inhibition of Helicobacter pylori and Its Associate Urease by Labdane Diterpenoids Isolated from Andrographis paniculata , 2016, Phytotherapy research : PTR.

[29]  Fernanda Canduri,et al.  Docking and small angle X-ray scattering studies of purine nucleoside phosphorylase. , 2003, Biochemical and biophysical research communications.

[30]  Y. Ghayeb,et al.  Atomic insight into designed carbamate-based derivatives as acetylcholine esterase (AChE) inhibitors: a computational study by multiple molecular docking and molecular dynamics simulation , 2018, Journal of biomolecular structure & dynamics.

[31]  Binsheng Yang,et al.  Spectral studies on the interaction between HSSC and apoCopC. , 2014, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[32]  José Marcio Machado,et al.  SKPDB: a structural database of shikimate pathway enzymes , 2010, BMC Bioinformatics.

[33]  J. H. Pereira,et al.  Dbmodeling , 2007, Cell Biochemistry and Biophysics.

[34]  Garland R. Marshall,et al.  An Automated Strategy for Binding-Pose Selection and Docking Assessment in Structure-Based Drug Design , 2016, J. Chem. Inf. Model..

[35]  Nelson Jose Freitas da Silveira,et al.  Molecular Modeling Databases: A New Way in the Search of Protein Targets for Drug Development , 2007 .

[36]  Walter Filgueira de Azevedo,et al.  The inhibition of 5-enolpyruvylshikimate-3-phosphate synthase as a model for development of novel antimicrobials. , 2007, Current drug targets.

[37]  A. Murray,et al.  Cyclin-dependent kinases: regulators of the cell cycle and more. , 1994, Chemistry & biology.

[38]  Khalida Bano,et al.  Conformational analysis (geometry optimization) of nucleosidic antitumor antibiotic showdomycin by Arguslab 4 software. , 2009, Pakistan journal of pharmaceutical sciences.

[39]  Walter Filgueira de Azevedo,et al.  Computational methods for calculation of ligand-binding affinity. , 2008, Current drug targets.

[40]  S. Parasuraman,et al.  Effect of cleistanthin A and B on adrenergic and cholinergic receptors , 2011, Pharmacognosy magazine.

[41]  J. Azevedo.  Shikimate kinase, a protein target for drug design. , 2014 .

[42]  Val Oliveira Pintro,et al.  Supervised machine learning techniques to predict binding affinity. A study for cyclin-dependent kinase 2. , 2017, Biochemical and biophysical research communications.

[43]  W. F. Azevedo.  MolDock applied to structure-based virtual screening. , 2010 .

[44]  Ruiwen Zhang.  Preface: Scientific Premise and Rigors in Scientific Research, Peer Review, Editing and Publishing. , 2017, Current cancer drug targets.

[45]  Val Oliveira Pintro,et al.  Development of CDK-targeted scoring functions for prediction of binding affinity. , 2018, Biophysical chemistry.

[46]  Sung-Hou Kim,et al.  Crystal structure of cyclin-dependent kinase 2 , 1993, Nature.

[47]  P E Bourne,et al.  The Protein Data Bank. , 2002, Nucleic acids research.

[48]  W. F. de Azevedo,et al.  Crystallographic and docking studies of purine nucleoside phosphorylase from Mycobacterium tuberculosis. , 2010, Bioorganic & medicinal chemistry.

[49]  Binsheng Yang,et al.  Study on the interaction between curcumin and CopC by spectroscopic and docking methods. , 2017, International journal of biological macromolecules.

[50]  W. F. de Azevedo,et al.  Structural basis for both pro- and anti-inflammatory response induced by mannose-specific legume lectin from Cymbosema roseum. , 2011, Biochimie.

[51]  Ramkumar Hariharan,et al.  Detailed Comparison of the Protein-Ligand Docking Efficiencies of GOLD, a Commercial Package and ArgusLab, a Licensable Freeware , 2006, Silico Biol..

[52]  Sali Veeresh Kumar,et al.  Butyrylcholinesterase in metabolic syndrome. , 2010, Medical hypotheses.

[53]  S H Kim,et al.  Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Val Oliveira Pintro,et al.  Understanding the Structural Basis for Inhibition of Cyclin-Dependent Kinases. New Pieces in the Molecular Puzzle. , 2017, Current drug targets.

[55]  Sven Hellberg,et al.  Discovery of novel potent and highly selective glycogen synthase kinase-3β (GSK3β) inhibitors for Alzheimer's disease: design, synthesis, and characterization of pyrazines. , 2012, Journal of medicinal chemistry.

[56]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[57]  M. Ramanathan,et al.  Prediction of estrogen receptor β ligands potency and selectivity by docking and MM-GBSA scoring methods using three different scaffolds , 2012, Journal of enzyme inhibition and medicinal chemistry.

[58]  A. Sami,et al.  Identification of novel catalytic features of endo-β-1,4-glucanase produced by mulberry longicorn beetle Apriona germari , 2007, Journal of Zhejiang University SCIENCE B.

[59]  Zukang Feng,et al.  The Protein Data Bank and structural genomics , 2003, Nucleic Acids Res..

[60]  Bikash R. Sahoo,et al.  Exploration of the binding modes of buffalo PGRP1 receptor complexed with meso-diaminopimelic acid and lysine-type peptidoglycans by molecular dynamics simulation and free energy calculation. , 2014, Chemico-biological interactions.

[61]  Walter Filgueira de Azevedo.  Opinion Paper: Targeting Multiple Cyclin-Dependent Kinases (CDKs): A New Strategy for Molecular Docking Studies. , 2015 .

[62]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[63]  Gabriela Bitencourt-Ferreira,et al.  Cyclin-Dependent Kinase 2 in Cellular Senescence and Cancer. A Structural and Functional Review. , 2019, Current drug targets.